In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment. Sue's ...

Ken Lee is a former writer at PEOPLE. Before joining PEOPLE, he worked as a Middle East foreign correspondent. PEOPLE, a Dotdash Meredith Brand, delivers the most trustworthy celebrity news and ...

In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.